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Regulation  of the  avidity  of an  antibody  response  by T  lymphocytes  may 
require  the  ability  of the  T  cell  or  its  product  to  distinguish  between  cells 
which  presumably  differ  only  in  the  avidity  of the  immunoglobulin  they 
secrete. The most likely means by which this difference could be expressed at 
the  level of the  B  cell would be by the  varying capacities of B  cells to bind 
antigens  to their  surfaces.  These  antigen  molecules in turn  could be specific 
targets for T cells or their products. 
Elsewhere  (1),  we describe a  suppressor T-cell  activity which  inhibits  high 
avidity IgG antibody secretion within 90 min. This suppression is mediated by 
carrier-specific T cells. Expression of the activity appears independent of helper 
T  cell  and  macrophage  function;  it  most likely  involves direct  action  on the 
hapten-specific antibody-secreting cell itself. We demonstrate here that hapten 
carrier  on the surface of high  avidity plaque-forming  cells  (PFC) 1 most likely 
provides the  necessary target  for the suppressor cell.  This  implies that  some 
specific B lymphocytes normally bear immunogen on their surfaces for at least 
several days. This bound antigen  could be important to the maintenance  and 
regulation of the normal immune response. 
Materials  and  Methods 
Animals.  AKR/Nat mice were obtained from the National Laboratories,  Creve Coeur. Mo. 
Antigens and Immunizations.  Keyhole limpet hemocyanin  (KLH)  (Calbiochem, San Diego, 
Calif.) and ovalbumin (EA) (Miles Laboratories Inc.,  Elkhart,  Ind.)  were conjugated with 2,4- 
dinitrofluorobenzene (DNP). DNP/KLH ratio was 7.4 groups/100,000 daltons; DNP/EA ratio was 
19 groups/molecule. Conjugation ratios were determined from absorbance at 360 nm at a  known 
protein concentration.  5- to 8-wk-old female mice were immunized by i.m. injections of 100/~g of 
hapten  protein  emulsified in  complete  Freund's  adjuvant  (CFA)  (Difco Laboratories,  Detroit, 
Mich.).  A  secondary  response  was  induced  by the i.p.  administration  of 100  pg of antigen  in 
saline at least 4 wk after primary immunization. Five mice comprised each experimental group. 
Antisera.  Goat anti-mouse ~-serum was described previously (1); rabbit anti-mouse IgG was 
purchased from Miles Laboratories Inc., and Gateway Immunosera (Cahokia,  Ill.). Normal and 
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Abbreviations  used in this paper:  ATC, activated T cells; CFA, complete Freund's adjuvant; 
DNP,  2,4-dinitrofluorobenzene;  EA,  ovalbumin;  FCS fetal  calf serum;  Fl-anti-Ig,  fluorescein- 
labeled rabbit anti-mouse Ig; KLH, keyhole limpet hemocyanin; PBS, phosphate-buffered saline; 
PFC,  plaque-forming cells; SRBC,  sheep  erythrocytes;  TNP-SRBC,  2,4,6-trinitrophenyl-coated 
sheep erythrocytes. 
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anti-KLH hyperimmune guinea pig sera were the gifts of Dr. Joyce Schroer (Washington Univer- 
sity, St. Louis Mo.). These sera were heat inactivated at 56°C for 40 rain; Ig fractions were then ob- 
tained by 40,  and then 50% ammonium sulfate precipitations. After extensive dialysis against 
phosphate-buffered saline (PBS), these preparations were absorbed for 1 h  at 4°C with equal vol- 
umes of both packed sheep erythrocytes (SRBC) and normal AKR mouse spleen cells. 
Activated T Lymphocytes.  AKR/Nat mice  (8- to  12-wk-old) were lethally irradiated  (750 R) 
and received 108 syngeneic thymocytes i.v. from 5-wk-old donors the same day. 100 ~g of antigen 
(hapten-carrier conjugate  or  carrier  alone)  in  saline  was  administered i.p.  7  days  later,  and 
spleens were  removed and teased,  yielding  ---107 cells per spleen.  Viability of this population 
ranged from 15 to 30%. It has been previously shown (1) that the suppressor activity in this cell 
population depends  on Thy-1  bearing,  nylon nonadherent T  cells.  Whether activated  against 
DNP-carrier protein or carrier alone, such activated T cells (ATC) do not demonstrate significant 
direct or indirect DNP-specific PFC  (<20 direct PFC and <1 indirect PFC/106 viable cells). 
Suppressor Cell Assay.  Spleen cells (8-10 ×  106) of DNP-KLH immune mice were mixed with 
107 antigen-primed ATC and incubated at 37°C for 90 min in 1.0 ml of minimal essential medium, 
Hanks' base, containing 10% fetal calf serum (FCS). In some experiments, ATC and/or hyperim- 
mune spleen cells were pretreated with antigen or antibody preparations (see Results). After this 
incubation, the suspension was diluted appropriately for counting ---200-300  PFC per slide. 
Plaque Assay.  Antibody-secreting splenocytes  (PFC)  were assayed by a  modification of the 
localized  hemolysis  technique  in  agarose  with  2,4,6-trinitrophenyl-coated  sheep  erythrocytes 
(TNP-SRBC)  (2).  Indirect PFC were quantitated by inhibition of >95% of direct PFC with goat 
anti-mouse ~-serum (at 1:4,000 final dilution) incorporated into the slide gel, and facilitation of 
indirect PFC with rabbit anti-mouse IgG at 1:200 dilution. 
The plaque assay technique was further modified to delineate the avidity of secreted antibody 
by  a  hapten inhibition method  (1).  e-DNP-L-lysine  was  incorporated  in the  gel  in five molar 
concentrations: 10-4-10  -8 M; in some experiments, 10  -4 M was omitted. An avidity subgroup was 
defined as those PFC present at a  given inhibitor concentration, but absent at the next higher 
concentration. Thus, six avidity subgroups are created, named as the negative log of the molar 
concentrations of the inhibitor: <8 (highest avidity), 7-8, 6-7, 5-6, 4-5, >4 (lowest avidity). 
Cell counts and viabilities were determined on a  4800A Cytofluorograf (Bio/Physics Systems 
Inc., Mahopac, N.  Y.). 
Pronase Treatment of Lymphoid Populations.  Approximately 80  x  10  e hyperimmune spleno- 
cytes, previously maintained in a  protein-free medium, were incubated with 5.0 mg pronase CB 
(Calbiochem, San Diego, Calif.) and 100 ~g DNase 1 (Worthington Biochemical Corp., Freehold, 
N.  J.)  in a  total volume of 1.0 ml for 15 rain at 37°C.  Immediately thereafter, 2.0 ml FCS was 
added and the suspension centrifuged. After washing, the cells were maintained in a  10% FCS 
medium. The Ig-bearing subpopulation of hyperimmune cells before and after pronase treatment 
was  quantitated  using a  fluorescein-labeled rabbit anti-mouse  Ig  (Fl-antigen-Ig)  (3).  Normal 
splenocytes contained 47% Ig-bearing cells; after pronase treatment, only 7% possessed detectable 
Ig.  After pronase treatment, the hyperimmune spleen cells were suspended in Eagle's Minimal 
Essential Medium with Hanks' Balanced Salt Solution, supplemented with glutamine, nonessen- 
tial amino acids, and sodium pyruvate with 10% FCS. 35 x  10-ram Petri dishes (Falcon Plastics, 
Div. of BioQuest,  Oxnard,  Calif.) were employed for culture,  and each contained 2.0 ml of the 
suspension, ---2 ×  107 cells. The dishes were incubated for 20 h  at 37°C in a  humidified, 5% CO2 
atmosphere, to allow regrowth of surface Ig. 
B and T lymphocytes from the cultured cells were separated after rosette formation with TNP- 
SRBC and the rosette-forming cells were later plaqued. Rosettes were made by a  modification of 
the method of Parish et al.  (4). Briefly, a  0.2-ml cell suspension (---2 ×  107 cells) was mixed with 
0.2 ml 10% (vol/vol) TNP-SRBC and centrifuged at 700 g  for 5 min at 4°C.  4 ml PBS prewarmed 
to  20°C  was  added,  and  the  pellet  gently  resuspended.  The  resulting  suspension  was  then 
carefully layered onto 4.0 ml Ficoll-Hypaque, prewarmed to 20°C and centrifuged at 2,000 g  for 20 
rain at 20°C.  The separating medium was 10% Ficoll (Pharmacia Fine Chemicals, Piscataway, N. 
J.) wt/vol, and 9.6% Hypaque  (Winthrop Laboratories, New York) vol/vol. After centrifugation, 
TNP-SRBC in the pellet were lysed with a buffered NH4C1 solution at 4°C (5), and the remaining 
lymphocytes were washed extensively before plaque assay.  These cells were 98% Ig-bearing by 
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Statistical  Analysis.  PFC/IO  s viable cells were determined for each avidity group and geometric 
means  and  standard  errors calculated.  As each experimental group  was  composed of splenic 
aliquots from each hyperimmune mouse, the paired t  test was used to test significance. Each 
experiment shown is one of two replicate studies. 
Results 
Modification of Hyperimmune Cell Sensitivity to Suppression.  The inhibi- 
tion of high but not low avidity PFC by carrier-activated T lymphocytes added 
at assay (1) suggests that high avidity membrane Ig, unlike that of low avidity 
PFC, might bind hapten carrier, and thus provide a  recognizable determinant 
for the  suppressing  cell.  If this  speculation  is  accurate,  hyperimmune cells 
might be  sensitized by incubation with hapten carrier but protected by anti- 
carrier antibody. 
In  the  first  experiment,  spleens  were  removed  from  mice  primed  10  wk 
before with DNP-KLH in CFA and boosted 4 days before assay with DNP-KLH 
in saline. Splenic aliquots were incubated on ice for 1 h with 10 ftg/ml of KLH, 
DNP-EA,  or  DNP-KLH.  The cells were washed twice with antigen-free me- 
dium,  and the hyperimmune cells were incubated for 90 min at 37°C in the 
presence  of 10  ×  106  KLH ATC just before plaque  assay.  Fig.  1 A  presents 
groups which were preincubated with antigen but did not receive ATC,  and 
demonstrates that  antigen administration alone  does  not  affect the  avidity 
profile.  Total  PFC/106  are  also  unaffected. In contrast, the  addition of ATC 
without antigen provokes a  marked high avidity suppression  (Fig.  1 B, P  < 
0.001  for avidity subgroup <8; P  <  0.05 for 7-8)  and a  significant decrease in 
total  PFC/106  cells.  The  preincubation of hyperimmune cells with  10  ~g/ml 
KLH or DNP-EA before ATC treatment has no effect on total PFC/10  ~ or the 
avidity profile.  However,  preincubation with DNP-KLH depresses  the  ATC- 
modulated response significantly (P <  0.01 for avidity subgroup 6-7; P  <  0.05 
for total PFC/106).  In all experiments presented here, both direct and indirect 
PFC were measured. In no case, however, were the direct PFC responses of the 
experimental groups different from controls, so only indirect PFC are presented. 
In the second experiment, DNP-KLH hyperimmune splenocytes were prein- 
cubated in a  1.0-ml volume for 1 h  at 4°C with 0.13  mg anti-KLH or 0.17  mg 
normal Ig. After washing twice, these cells were incubated with 107 KLH ATC. 
Table I demonstrates that preincubation with antibody had no influence on the 
normal secondary response (groups 1-3),  but with the addition of ATC, PFC in 
avidity subgroup <8 are significantly inhibited (group 4: P  <  0.001) even after 
preincubation with guinea pig  Ig  (group  6:  P  <  0.001).  On  the  other  hand, 
preincubation with anti-KLH (group 5) completely protects from ATC suppres- 
sion. 
Suppression  Blockade  by Soluble  Carrier.  The previous experiments dem- 
onstrate as predicted that KLH does not influence suppression when preincu- 
bated  with  DNP-KLH  hyperimmune cells.  On  the  other  hand,  function of 
carrier-specific suppressor T cells might be altered by soluble KLH. 
KLH-primed ATC  were  suspended in  medium containing 10  ftg/ml KLH, 
DNP-KLH, EA, or DNP-EA, and left on ice for 1 h. The cells were then washed 
twice and 8  ×  106 ATC were incubated with DNP-KLH hyperimmune spleno- 
cytes; Table II gives the data obtained at PFC assay. High avidity PFC, given 1630  MEDIATION  OF  T-CELL  SUPPRESSION 
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FIG.  1.  Modification of suppression by preincubation of hyperimmune cells with antigen. 
Mice were given 100  /~g DNP-KLH  in CFA in the thighs, followed 10 wk later by 100/~g 
DNP-KLH  in saline i.p. Just before PFC assay 4 days later, immune spleen subfractions 
(about 8  x  10  e cells) were preincubated with no antigen, 10  /~g/ml KLH,  10 /~g/ml DNP- 
EA, or 10/~g/ml DNP-KLH.  After washing, these cells were (B) or were not (A) incubated 
for 90 min at 37°C with 107 KLH ATC.  Total indirect PFC/10  ~ were significantly reduced 
for all groups receiving ATC  (P <  0.01) and of these, preincubation of hyperimmune cells 
with DNP-KLH further reduced total PFC/106 (P <  0.05). Direct PFC were unaffected. 
TABLE  I 
Protection against Suppression  by Anti-Carrier Antibody;  Preincubation  with 
Hyperimmune Cells* 
Group  Immunoglobulin 
pulse  KLtt ATC 
Indirect PFC/10  e viable cells* 
Total  <8  >8 
1  -  0  4,476(1.12)  656(1.32)  3,673(1.16) 
2  anti-KLH  0  5,290(1.09)  798(1.36)  4,207(1.15) 
3  NGP  0  4,745(1.19)  879(1.17)  3,792(1.22) 
4  -  107  3,332(1.15)**  0  ***  3,332(1.15) 
5  anti-KLH  107  5,013(1.13)  1,267(1.21)  3,709(1.11) 
6  NGP  107  3,886(1.20)  0  ***  3,686(1.20) 
* Primary immunization,  100/~g DNP-KLH  in CFA; secondary,  100  /~g DNP-KLH  in saline, 8 
wk later; just before assay 4 days later,  107 hyperimmune splenocytes were incubated for 1 h, 
0°C  with 0.13 mg/ml anti-KLH Ig or 0.17  mg/ml normal guinea pig (NGP) Ig,  then washed; 
KLH ATC were added, and incubated 90 rain at 37°C. 
Geometric means, and in parentheses, standard error factors.  Significance, denoted as *(P  < 
0.05), **(P <  0.01), or ***(P <  0.001), was computed by paired t test, comparing vs. group 1. 
for avidity  subgroup  <7,  show  complete  protection  from  suppression  when  ATC 
were  preincubated  with  KLH  (group  3).  Excellent  high  avidity  suppression  (P 
<  0.05)  was  observed  for all other  ATC  preincubations  (groups  2,  4-6). 
KLH  also  provokes  a  dose-dependent  blockade  of suppression  when  added  to ROBERT  W.  WARREN  AND  JOSEPH  M.  DAVIE  1631 
TABLE  II 
Specificity  of Inhibition of ATC Function by Antigen Preincubation  with ATC* 
Group  Antigen pulse  KLH ATC 
Indirect  PFCII0  s  viable cells$ 
Total  <7  >7 
1  0  0  3,867(1.33)  710(1.71)  3,064(1.29) 
2  0  8 × 108  3,097(1.24)*  33(2.63)*  2,793(1.23) 
3  KLH  8  x  106  3,899(1.25)  675(1.12)  3,208(1.28) 
4  DNP-KLH  8 x  106  3,259(1.29)*  13(1.21)***  3,245(1.29) 
5  EA  8 x  10  e  3,540(1.26)  31(2.43)*  3,442(1.25) 
6  DNP-EA  8 × 106  3,833(1.26)  119(3.77)*  3,442(1.28) 
* Primary immunization, i00 ~g DNP-KLH  in  CFA; secondary immunization, i00 ~g DNP-KLH 
in saline, 10 wk later; 4 days later,  just  before assay, KLH  ATC  were incubated for 1 h, 0°C 
with 10 ~g/ml KLH, DNP-KLH,  EA, or DNP-EA, then washed; 8 x 106 ATC were added to 10  v 
hyperimmune splenocytes and incubated for 90 rain  at 37°C. 
Geometric means, and in parentheses, standard error  factors.  Significance,  denoted as *(P < 
0.05),  **(P < 0:01),  or ***(P < 0.001),  was computed by paired t  test,  comparing vs. group 1. Of 
groups 3-6,  only group 3 was significantly  different  from group 2 (P < 0.01). 
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Fro.  2.  Dose-dependent inhibition of suppression by soluble carrier. The primary immu- 
nization, 100/~g DNP-KLH in CFA, was given 7 wk before the secondary of 100/~g DNP- 
KLH in saline. Just before assay 4 days later, ~9  x  10  e hyperimmune spleen cells were 
mixed (B), or not mixed (A) with 107 DNP-KLH ATC, suspended in varying concentrations 
of KLH, and incubated for 90 min at 37°C. Total indirect PFC/10 e were reduced only for the 
group incubated with ATC but without KLH (P < 0.01). Direct PFC were unaffected. 
the  ATC-hyperimmune  cell  incubation  mixture.  Hyperimmune  splenocytes 
were mixed with l0  T DNP-KLH  ATC in a  total volume of 1.0 ml containing 0, 
0.1,  1, or 10/~g of KLH per ml, incubated at 37°C for 90 rain, and then assayed. 
Fig.  2  shows  that  KLH  did  not  influence the .response  when  ATC  were  not 
present (A).  ATC alone produced an exceptional deletion of high avidity PFC 
(P  <  0.001  for  avidity group  <8;  B).  The  administration  of 0.1  /~g/ml  KLH 1632  MEDIATION  OF  T-CELL  SUPPRESSION 
TABLE  HI 
Loss and Recovery of Suppressibility after Pronase Treatment of Hyperimmune Cells 
Immune splenocyte pretreatment*  Indirect  PFC/10  e  viable  cells* 
C~t~e 
DNP-KLH 
Group  Prenase  ~rlg  pulse  KLH ATC  Total  <8  >5 
regrowtb 
1  0  0  0  0  3,359(1.28)  482(1.31)  2,859(1.29) 
2  0  0  0  10  ~  2,767(1.33)*  10(1.23)***  2,755(1.33) 
3  +  0  0  0  2,266(1.37)**  209(2.23)  1,852(1.42)* 
4  +  0  0  107  2,156(1.37)**  226(2.37)  1,659(1.42)* 
5  +  +  0  0  72,277(L67)  15,662(1.96)  55,458(1.60) 
6  +  +  0  l0  T  52,949(1.37)  13,607(1.26)  36,547(1.56) 
7  +  +  10 ~g/ml  0  59,889(1.65)*  10,934(1.76)  41,512(1.74) 
8  +  +  10 pg/ml  107  45,958(1.68)*  164(1.74)***  45,766(1.68) 
* Primary immunization, 100 ~g DNP-KLH in CFA; secondary, 100 ~g DNP-KLH in saline, 6 wk later; immediately before assay 
4 days later, hyperimmune spleen cells were treated with pronase, then incubated for 90 min at 37°C with 10  T KLH ATC. One 
set of pronase.treated hyperimmune cells, before incubation with ATC, were placed in culture for 20 b at 37°C in 5% CO2; the 
population  was  rosetted  with  TNP-SRBC,  then  incubated  for  1  h  on  ice  with  10  ~g/ml  DNP-KLH;  aRer  washing  the 
hyporimmune cells twice, 107 KLH ATC/ml were added, and incubation proceeded for 90 rain at 37°C. Appreximately 8 x  106 
hyperimmune cells comprised each group. Total PFC recovery from group 3 to group 5 •-30%. 
* Geometric means,  and in parentheses,  standard error factors. Signifieanc  ~. denoted as *(P  <  0.05),  **(P  <  0.01),  or ***(P  < 
0.001),  was computed by paired t test, comparing groups 2-4 vs. 1 and 6-5 ~s.  5. 
with ATC  did not diminish this  suppression.  Incubation with 1 or i0 ftg/ml 
KLH, on the other  hand, produced entirely  normal avidity  profles. 
Pronase Treatment of Hyperimmune  Cells. The ability  of DNP-KLH  to 
preferentially  sensitize  high avidity PFC  to KLH  ATC  implicates hapten- 
specific  membrane Ig in the suppression.  This idea,  as well as the correlate 
that hapten carrier  is required for suppression,  was tested in the following 
manner. 
Hyperimmune spleen cells  removed from mice primed 6 wk and boosted 4 
days earlier  with DNP-KLH  were optionally  treated  with pronase according  to 
the procedure given in Materials and Methods, and then incubated with 107 
KLH  ATC (Table  III).  Other aliquots  of  pronase-treated  cells  were cultured  for 
20 h to allow membrane protein  regrowth, treated  with TNP-SRBC, and their 
rosettes  were isolated.  The cell  population  freed  of  erythrocytes  was optionally 
suspended in 10 ~g/ml DNP-KLH  on ice for 1 h, washed twice, and then 
incubated with 10 × 106 KLH  ATC. Pronase treatment alone (Table III,  group 
3) and antigen incubation of the cultured cells  (group 7) produced minor, 
avidity  nonspecific  PFC depression.  In our experience,  this  is not unusual for 
extended experimental manipulation. Pronase treatment before  ATC adminis- 
tration (group 4) completely protects  high avidity  PFC from suppression by 
KLH  suppressor cells  (group 2;  P < 0.001  for avidity  subgroup <8).  Moreover, 
pronase-treated  hyperimmune cells  do not recover  suppressibility  with culture 
(groups 5 and 6), as PFC for subgroup <8 demonstrates, unless the cells  are 
incubated with DNP-KLH  before  mixing with KLH ATC (groups  7 and 8).  This 
result  strongly  implies  that  the  target  for  KLH-specific suppression  in  untreated 
splenocytes  is  cell-bound  hapten-carrier  conjugates. 
Loss of  Suppressor Carrier  Specificity.  It is shown elsewhere (1) that EA 
ATC  do not suppress DNP-KLH  hyperimmune  cells.  However, this  carrier 
specificity  may not depend completely on differences  between EA- and KLH- 
activated  T cells.  Indeed, carrier  specificity  may simply mirror the identity  of ROBERT  W.  WARREN  AND  JOSEPH  M.  DAVIE  1633 
T,,.BLZ IV 
Antigen-Mediated  Shift in the Carrier Specificity of Suppression  of DNP-KLH-Primed 
Splenocytes* 
Group  Antigen pulse  EA ATC 
Indirect  PFC/10  e  viable  cells$ 
Total  <8  >8 
1  0  0  3,108(1.43)  705(2.37)  2,191(1.28) 
2  EA  0  2,931(1.28)  675(1.28)  2,208(1.21) 
3  DNP-EA  0  3,360(1.15)  852(1.40)  2,324(1.21) 
4  EA+  DNP-KLH  0  2,940(1.21)  124(2.32)  2,532(1.25) 
5  0  107  2,800(1.21)  819(1.14)  1,851(1.41) 
6  EA  107  2,869(1.25)  1,189(1.25)  1,652(1.28)* 
7  DNP-EA  107  2,178(1.18)**  13(1.21)***  2,165(1.18) 
8  EA+DNP-KLH  107  3,003(1.17)  558(2.26)  1,949(1.75) 
* Primary immunization, i00 /~g DNP-KLH  in CFA; secondary, I00 ~g DNP-KLH  in saline,  6 
wk later;  just  before  assay  4 days  later,  8 x 106  immune spleen  cells  were preincubated with 10 
~g/ml EA, DNP-EA, or 10 /~g/ml  each of EA and DNP-KLH  for 1 h at 37°C. The cells  were 
washed twice,  then incubated with 107  EA ATC for  90 rain  at 37°C. 
Geometric means, and in parentheses, standard error  factors.  Significance,  denoted as *(P < 
0.05),  **(P < 0.01),  or ***(P < 0.001)  was computed by paired  t  test.  Comparisons were made 
between groups preincubated with identical  Ag preparations. 
the  hapten-carrier  conjugate  available  to  ATC  and  high  avidity  antibody- 
secreting cells. This possibility was evaluated as follows. 
DNP-KLH hyperimmune splenocytes were preincubated in a total volume of 
1.0 ml with 10/~g/ml EA, DNP-EA, or 10/~g/ml of both EA and DNP-KLH. After 
1 h  at 4°C, these cells were washed twice, incubated at 37°C for 90 min with or 
without  107  EA  ATC,  and  assayed.  Table  IV  shows  that  the  inclusion  of 
antigen  alone  (groups  2-4)  does not significantly  affect total  or high  avidity 
PFC. In the presence (group 6) or absence (group 5) of EA, EA ATC also do not 
influence  the  response.  Similarly,  the  addition  of DNP-KLH  to  EA  in  the 
preincubation mixture (group 8) has no effect. On the other hand, preincubation 
with DNP-EA (group 7) provokes significant  reductions in both total PFC/106 
(P <  0.01) and PFC/10  s in the <8 avidity subgroup (P <  0.001). 
Discussion 
A  suppressor mechanism consistent with these data requires hapten carrier 
on  the  surface  of high  avidity  B  cells,  presumably  bound by membrane  Ig. 
Evidence to support this hypothesis is reasonably strong. The in vitro exposure 
of DNP-KLH  hyperimmune  cells  to  DNP-KLH  but  not  KLH  or  DNP-EA, 
sensitizes the population to KLH ATC, producing an avidity-dependent increase 
in the observed suppression. In a related experiment, DNP-KLH hyperimmune 
cells become sensitive to  EA ATC  (contrary to the normal  carrier  specificity 
[1])  if hyperimmune  cells are preincubated  with  DNP-EA but not EA alone, 
nor  EA  mixed  with  DNP-KLH.  Thus,  we  propose that  high  avidity  B  cells 
recognize and bind specific haptenic determinants  of the hapten-carrier  conju- 
gate,  and  thereupon  gain  surface  carrier  determinants  which  then  serve  as 
targets  for  carrier-specific  suppressor  T  cells  and/or  their  soluble  products, 
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DNP-KLH hyperimmune cells are protected from KLH ATC by prior incubation 
with anti-KLH but not normal guinea pig Ig. Moreover, KLH ATC activity is 
specifically blocked by incubation with KLH (but not DNP-KLH) before mixture 
with  target  cells.  This  dichotomy favors  a  theory  of physical  blockade  of 
suppressor  molecules by  KLH  (presumably  DNP-KLH  bound  to  suppressor 
would  be  an  active  complex),  although  the  carrier  might  also  signal  an 
alteration in suppressor cell function.  KLH produces a  dose-dependent emer- 
gence of high avidity PFC when added to the ATC-hyperimmune cell mixture, 
and lower avidity suppressible PFC are first protected. This finding is consistent 
with the concept that lower avidity PFC, possessing fewer targets for suppressor 
binding,  would first  escape  a  suppression  threshold in  a  suppressor-limited 
system. Finally, and most impressive, is the loss of sensitivity of hyperimmune 
cells to ATC by prior treatment with pronase,  suggesting the importance of 
membrane-bound proteins.  In our hands,  <5%  of the cells bear Ig after this 
treatment, but recovery of membrane Ig occurs after 24 h in tissue culture (3), 
shown here by excellent concentration of PFC among immune rosetting cells 
after culture. Nevertheless, such DNP-KLH hyperimmune cells are not sensi- 
tive to KLH ATC, unless these cells are first incubated with DNP-KLH. 
These results imply that hapten carrier normally remains at the surface of 
high avidity anti-DNP  PFC  for at  least 4 days after boost.  Presumably this 
requires both antigen and high affinity Ig. Although there has been difficulty 
in demonstrating membrane Ig on PFC (6, 7), McConnell (8), Nossal and Lewis 
(9),  and Greeley and Scott (10) have largely resolved these discrepancies with 
the finding that membrane Ig decreases with time after the secondary immuni- 
zation. Unlike McConnell, however, Bankert et al.  (11) were unable to demon- 
strate rosetting indirect PFC.  In agreement with McConnell (8),  Nossal  and 
Lewis  (9)  concluded that 90%  of 4-day secondary PFC  possess  membrane Ig, 
compared to  40%  of 23-day secondary PFC.  High  avidity antibody-secreting 
cells  most  likely  have  high  avidity  membrane Ig  (12),  consistent  with  the 
mechanistic theory presented here for T-cell-mediated suppression. 
The question remains, however, if hapten carrier can be found at the PFC 
surface.  Bystryn et al.  (13) concluded that  antigen may bind to  cells in the 
secondary response even in the presence of high concentrations of circulating 
antibodies.  In  their  experiments,  DNP-bovine  serum  albumin  still  bound 
specifically to MOPC 315 cells when a  1,000-fold molar excess of soluble MOPC 
315 Ig was included. Their expectation for the circulating antibody to circulating 
antigen ratio in the secondary response was <100. On the other hand, primed 
antigen-binding cells (not selected for antibody secretion) shed or endocytose 
antigen-membrane Ig complexes within  2  h  of 37°C incubation in  vitro  (3). 
Still,  small  but  functionally significant amounts of surface antigen  may be 
protected from breakdown  and  elimination,  as  occurs  in  macrophages  (14). 
Otherwise, lymphocyte surface-localized antigen would theoretically depend on 
the continual presence of antigen in the lymphocyte microenvironment. Antigen 
localizes in splenic follicles, found long after circulating antigen levels are quite 
low (15,  16). In fact, Ingraham (17) found 4% of a  secondary immunization of 
35S-sulfanilic acid-azo-bovine T-globulin in the spleen many weeks after boost. 
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localization  since thoracic  duct drainage  reduces follicular  antigen  uptake,  a 
reduction  only partly  relieved by passive immunization  (18).  Nevertheless,  a 
demonstration  of antigen  at  the  surface  of hyperimmune  cells has  not been 
reported; in fact, Aldo-Bensen and Borel (19) were unable to show significant 
binding  of  anti-DNP  antibody  to  spleen  cells  of  mice  given  four  weekly 
injections of DNP-KLH i.v. Conceivably, these results may reflect a very small 
population  of  high  avidity  cells  (in  view  of  the  immunization  procedure) 
concealed in a  relatively high background response.  Present  attempts in this 
laboratory  are  focusing  on  the  demonstration  of KLH  determinants  at  the 
surface of DNP-specific PFC. 
Given  the  crucial  role  of antigens  in  mediating  suppressor  T-cell  activity, 
other  aspects  of  antigenic  immunoregulation  should  be  reconsidered.  For 
example, antigens  may well mediate carrier-specific helper T-cell and hapten- 
specific precursor communication.  Particularly  relevant is the recent work of 
Feldbush and van der Hoven (20),  and  Celada et al.  (21),  who showed that  a 
high  dose secondary immunization  resulted  in  large  amounts  of low affinity 
antibodies.  This  result  is  reminiscent  of increased  T-ceU suppression  among 
hyperimmune splenocytes presengitized with hapten carrier.  Unpublished data 
from our laboratory also suggest that  the  secondary immunization  dose may 
influence the extent of high avidity suppression in the in vivo suppressor T-cell 
system we reported previously (22). On the other hand, since Feldbush and van 
der Hoven (20) determined  serum antibody affinity,  it is unclear whether the 
reciprocal influence of high antigenic challenge  on affinity reflects deletion of 
high  affinity antibodies,  or a  vast increment  of lower affinity populations.  In 
any event, antigenic modulation of the secondary response, acting via suppres- 
sor T cells, could provide effective immune regulation, perhaps limiting immune 
complex formation in the animal. 
The possible relevance of this in vitro suppressor T-cell activity to tolerance 
is intriguing.  The system is certainly unrelated to antibody-mediated tolerance 
(23),  helper  T-cell  unresponsiveness  (24,  25),  and  the  immediate  tolerance 
induced  by polymeric antigens  in  spleen cells responding  to  DNP-Ficoll  (26). 
Nevertheless, antigen-dependent  T-cell suppression may interrelate the loss of 
high affinity antibodies in partially tolerant animals (27-30), the plausible role 
of suppressor cells in tolerance (31-33), and the firm demonstration of tolerogen 
at  the  surface  of tolerant  B  cells  (19,  34).  Considering  this  information  in 
detail,  Andersson et al.  (30),  as well as Rajewsky and Brenig  (35) found that 
high  dose but not low dose tolerance results  in a  decline of antibody avidity. 
Sanfilippo and Scott (24, 25) have shown that helper-cell unresponsiveness does 
not  provoke  a  shift  in  antibody  avidity.  Moreover,  Bell  and  Shand  (31) 
demonstrated a  T-dependent avidity suppression by tolerant  cells.  In another 
experiment  (36), these authors gave tolerant rats primed T or normal T and B 
cells, plus an antigen  challenge.  They found that a  T-helper cell deletion was 
indeed part of tolerance, but that the high avidity B-cell response was irrevers- 
ibly deleted,  and could not be reconstituted with  immune  or normal  T  cells. 
Furthermore,  primed  B-memory cells are  inhibited  upon transfer  to tolerant 
rats  (31).  Whereas  other  reports  would  tend  to  distinguish  the  suppressing 
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suppressed B  cells would quickly be released if the inhibitor were removed; 
transferred T cells were only suppressive if transferred soon after the induction 
of  tolerance.  Finally,  although  Aldo-Benson  and  Borel  (19, 34)  have  not 
investigated T-cell involvement or high avidity deletion in their tolerant B-cell 
population,  these  cells have been  shown to  carry surface-localized tolerogen 
(hapten  carrier).  Precisely like  the  suppressor  T-cell  system reported  here, 
they find release from this tolerance by anti-carrier antibody (38). 
In view of the preceding data, we propose that suppressor T cells are possibly 
involved in high zone tolerance, recognizing carrier determinants of antigen 
localized at the surface of high avidity B cells. On the other hand, we do not 
discount the  involvement and  importance  of the  tolerogen,  whose  chemical 
structure may facilitate continual lymphocyte surface presentation. Moreover, 
at least with some tolerogens (26), accessory cells are probably not required for 
tolerance induction. 
The crucial direction for investigation is the intracellular biology of suppres- 
sion. At the level of the suppressor T cell, preliminary evidence suggests that 
ATC  sonicates are  as  effective as the intact cell.  Such suppressor  molecules 
specific for a  single carrier may reflect a  variety of idiotypic specificities, and 
demonstrates strong or weak histocompatibility requirements as found in the 
suppressor  T-cell  systems  of Taniguchi  et  al.  (39-41)  and  Kapp  (J.  Kapp, 
personal  communication), respectively. The  intracellular events resulting in 
functional  deletion  of high  avidity  PFC  are  also  of considerable  interest; 
membrane  Ig  may  focus  suppressor  molecules  at  a  proximate  membrane 
receptor or permit concentration of  the factor in the cellular microenvironment, 
allowing sufficient cellular uptake for suppression. Finally, the reversibility of 
suppression has important implications for our postulated role of suppressor 
cells in tolerance, and indeed, in the humoral immune response as a whole. 
Summary 
Carrier-specific suppressor T  cells can suppress antibody secretion by high 
avidity IgG plaque-forming cells (PFC) within 90 min in vitro. This process can 
be blocked by the  inclusion of soluble carrier  in the  cell mixture or by the 
exposure of  target cells to anti-carrier antibodies or pronase. Moreover, suppres- 
sion can be augmented by PFC exposure to the soluble hapten-carrier conjugate. 
Finally, carrier  specificity may be  overcome by preincubation of the target 
population with a  hapten-heterologous carrier before addition of heterologous 
carrier  ATC.  Thus,  it is  likely that high avidity suppression depends upon 
immunogen bound to the surfaces of antibody-secreting cells which serves as a 
target for suppressor cells or molecules. 
Note Added in Proof.  It has come to our attention that recent shipments  of  AKR/Nat  mice are 
outbred. This has affected  the suppressor effect described in this paper. AKR/J (The Jackson 
Laboratory, Bar Harbor, Maine), but not AKR/Nat, now show late-acting suppression. 
We are grateful to Doctors Robert Nicolotti and Rogers Griffith for valuable discussion and 
assistance. 
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